Track the 신일제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 신일제약 has published 54 reports. The latest transaction was filed on 4 June 2026 (Sale). Among the most active insiders: 홍성소. All data is openly available.
54
Insider Decl.
n/a
Thresholds
n/a
8 ops.
Buy Volume
n/a
5 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.